Section 58-17b-625 - Administration of a long-acting injectable and naloxone(1) A pharmacist may, in accordance with this section, administer a drug described in Subsection (2).(2) Notwithstanding the provisions of Subsection 58-17b-102(58)(c)(ii)(B), the division shall make rules in collaboration with the board and, when appropriate, the Medical Licensing Board created in Section 58-67-201, and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.(3) A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist: (a) completes the training described in Subsection (2);(b) administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; and(c) is directed by the physician, as that term is defined in Section 58-67-102 or Section 58-68-102, who issues the prescription to administer the drug.Amended by Chapter 507, 2024 General Session ,§ 70, eff. 10/1/2024.Amended by Chapter 223, 2023 General Session ,§ 13, eff. 5/3/2023.Amended by Chapter 340, 2021 General Session ,§ 7, eff. 5/5/2021.Amended by Chapter 343, 2019 General Session ,§ 3, eff. 5/14/2019.Added by Chapter 384, 2017 General Session ,§ 4, eff. 5/9/2017.